Search Results - "NYKÄNEN, Antti I"
-
1
Creating superior lungs for transplantation with next-generation gene therapy during ex vivo lung perfusion
Published in The Journal of heart and lung transplantation (01-05-2024)“…Engineering donor organs to better tolerate the harmful non-immunological and immunological responses inherently related to solid organ transplantation would…”
Get full text
Journal Article -
2
Donor Simvastatin Treatment in Liver Transplantation: Post Hoc Analysis of a Randomized Placebo-controlled Trial With Long-term Follow-up
Published in Transplantation (01-04-2023)Get full text
Journal Article -
3
Targeting Lymphatic Vessel Activation and CCL21 Production by Vascular Endothelial Growth Factor Receptor-3 Inhibition Has Novel Immunomodulatory and Antiarteriosclerotic Effects in Cardiac Allografts
Published in Circulation (New York, N.Y.) (30-03-2010)“…Lymphatic network and chemokine-mediated signals are essential for leukocyte traffic during the proximal steps of alloimmune response. We aimed to determine…”
Get full text
Journal Article -
4
Mesenchymal Stromal Cell Therapy in Lung Transplantation
Published in Bioengineering (Basel) (01-06-2023)“…Lung transplantation is often the only viable treatment option for a patient with end-stage lung disease. Lung transplant results have improved substantially…”
Get full text
Journal Article -
5
Donor Simvastatin Treatment Abolishes Rat Cardiac Allograft Ischemia/Reperfusion Injury and Chronic Rejection Through Microvascular Protection
Published in Circulation (New York, N.Y.) (06-09-2011)“…Ischemia/reperfusion injury may have deleterious short- and long-term consequences for cardiac allografts. The underlying mechanisms involve microvascular…”
Get full text
Journal Article -
6
Upregulation of Coagulation Factor VIII and Fibrinogen After Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension
Published in Clinical and applied thrombosis/hemostasis (01-01-2023)“…Objectives Chronic thromboembolic pulmonary hypertension (CTEPH) is associated with thrombotic states including elevated coagulation factor VIII (FVIII)…”
Get full text
Journal Article -
7
VEGF Pathways in the Lymphatics of Healthy and Diseased Heart
Published in Microcirculation (New York, N.Y. 1994) (01-01-2016)“…Cardiac lymphatic system is a rare focus of the modern cardiovascular research. Nevertheless, the growing body of evidence is depicting lymphatic endothelium…”
Get full text
Journal Article -
8
Transcriptomic Landscape of Circulating Extracellular Vesicles in Heart Transplant Ischemia-Reperfusion
Published in Genes (01-11-2023)“…Ischemia-reperfusion injury (IRI) is an inevitable event during heart transplantation, which is known to exacerbate damage to the allograft. However, the…”
Get full text
Journal Article -
9
Critical Role of VEGF-C/VEGFR-3 Signaling in Innate and Adaptive Immune Responses in Experimental Obliterative Bronchiolitis
Published in The American journal of pathology (01-11-2012)“…Chronic inflammation, a hallmark of obliterative bronchiolitis, is known to induce lymphangiogenesis. We therefore studied the role of lymphangiogenic vascular…”
Get full text
Journal Article -
10
Lung Transplant Immunomodulation with Genetically Engineered Mesenchymal Stromal Cells-Therapeutic Window for Interleukin-10
Published in Cells (Basel, Switzerland) (17-05-2024)“…Lung transplantation results are compromised by ischemia-reperfusion injury and alloimmune responses. Ex vivo lung perfusion (EVLP) is used to assess marginal…”
Get full text
Journal Article -
11
Engineered mesenchymal stromal cell therapy during human lung ex vivo lung perfusion is compromised by acidic lung microenvironment
Published in Molecular therapy. Methods & clinical development (10-12-2021)“…Ex vivo lung perfusion (EVLP) is an excellent platform to apply novel therapeutics, such as gene and cell therapies, before lung transplantation. We…”
Get full text
Journal Article -
12
Platelet-derived Growth Factor-B Protects Rat Cardiac Allografts From Ischemia-reperfusion Injury
Published in Transplantation (01-02-2016)“…BACKGROUNDMicrovascular dysfunction and cardiomyocyte injury are hallmarks of ischemia-reperfusion injury (IRI) after heart transplantation. Platelet-derived…”
Get full text
Journal Article -
13
Effect of Triclosan-Coated Sutures on the Incidence of Surgical Wound Infection After Lower Limb Revascularization Surgery: A Randomized Controlled Trial
Published in World journal of surgery (01-10-2012)“…Background Surgical wound infection (SWI) is a common complication after peripheral vascular surgery. In a prospective study, triclosan-coated sutures were…”
Get full text
Journal Article -
14
PDGF-A, -C, and -D but not PDGF-B Increase TGF-β1 and Chronic Rejection in Rat Cardiac Allografts
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2009)“…Objective— Chronic rejection is the main reason for the poor long-term survival of heart transplant recipients and is characterized by cardiac allograft…”
Get full text
Journal Article -
15
Systemic overexpression of matricellular protein CCN1 exacerbates obliterative bronchiolitis in mouse tracheal allografts
Published in Transplant international (01-12-2015)“…Obliterative bronchiolitis (OB) involves airway epithelial detachment, fibroproliferation, and inflammation, resulting in chronic rejection and transplant…”
Get more information
Journal Article -
16
Increased myeloid cell hypoxia-inducible factor-1 delays obliterative airway disease in the mouse
Published in The Journal of heart and lung transplantation (01-05-2016)“…Background Obliterative bronchiolitis after lung transplantation is characterized by chronic airway inflammation leading to the obliteration of small airways…”
Get full text
Journal Article -
17
Donor simvastatin treatment and cardiac allograft ischemia/reperfusion injury
Published in Trends in cardiovascular medicine (01-04-2013)“…Abstract Ischemia/reperfusion injury of a transplanted heart may result in serious early and late adverse effects such as primary graft dysfunction, increased…”
Get full text
Journal Article -
18
Reconstruction of Donor Anomalous Pulmonary Vein During Lung Transplantation
Published in The Annals of thoracic surgery (01-08-2022)“…Pulmonary vein anomalies are rare but can complicate lung transplantation especially if unrecognized during the lung procurement operation. We describe a case…”
Get full text
Journal Article -
19
Combined Donor Simvastatin and Methylprednisolone Treatment Prevents Ischemia-Reperfusion Injury in Rat Cardiac Allografts Through Vasculoprotection and Immunomodulation
Published in Transplantation (15-05-2013)“…BACKGROUNDIschemia-reperfusion injury (IRI) and allograft dysfunction remain as two of the major clinical challenges after heart transplantation. Here, we…”
Get full text
Journal Article -
20
Access site complications in thoracic endovascular aortic repair
Published in Journal of vascular surgery (01-04-2024)“…Percutaneous access and use of vascular closure devices facilitate thoracic endovascular aortic repair (TEVAR) procedures during local anesthesia and allow…”
Get full text
Journal Article